News Focus
News Focus
icon url

scottsmith

01/03/19 6:35 PM

#253343 RE: Lemoncat #253324

Of course they were involved in the results. Or you think pfizer permitted use of their drugs without any interest in what happened? Pfizer had a front row seat and gave Kevetrin the big kiss off.
icon url

williamssc

01/03/19 7:19 PM

#253346 RE: Lemoncat #253324

You mean this study. January 24, 2013 PR. Research by BIDMC combined Kevetrin with sunitinib (marketed as Sutent by Pfizer), on cell line 786, a drug-resistant renal cancer. Cellceutix was advised by the researchers that “the Kevetrin/sunitinib combination is the first we’ve used in which actual tumor shrinkage is noted.” Seems Lab test conducted alone by Beth Israel.